P&G stock steadies in thin year-end trade as Wall Street slips
29 December 2025
1 min read

P&G stock steadies in thin year-end trade as Wall Street slips

NEW YORK, December 29, 2025, 12:31 ET — Regular session

  • P&G traded near flat as investors trimmed technology exposure in the final week of the year.
  • Consumer staples held steadier than the broader market, keeping defensive names in focus.
  • Investors are watching upcoming Fed releases and P&G’s January earnings update.

Shares of Procter & Gamble (PG) were little changed at $144.76 by 12:22 p.m. ET, after moving between $143.96 and $145.06 in a narrow range. Volume was about 2.3 million shares.

The muted move comes as investors close out the year with lighter trading and sharper intraday swings than usual.

In that backdrop, consumer staples — companies that sell everyday necessities — often act as a port in a choppy tape because demand tends to hold up even when growth scares flare.

U.S. stocks slipped as heavyweight tech names pulled back, a Reuters report said, denting hopes for a “Santa Claus rally” — the market’s typical late-December lift. “It’ll turn out to be a buying opportunity,” Hank Smith, director and head of investment strategy at Haverford Trust, said of the tech selloff, while investors also eyed upcoming Federal Reserve minutes and weekly jobless claims data; U.S. markets are shut Thursday for New Year’s Day. 1

The Consumer Staples Select Sector SPDR Fund (XLP) was flat, and peers were also subdued, with Kimberly-Clark down about 0.1%, Colgate-Palmolive off about 0.1% and Unilever down about 0.6%.

P&G, maker of Tide detergent and Pampers diapers, tends to trade as a “defensive” stock, meaning investors buy it for steady cash flows and resilience rather than rapid growth.

The next clear company catalyst is its fiscal second-quarter update: P&G said it will webcast a discussion of results on Jan. 22, 2026, starting at 8:30 a.m. ET. 2

Ahead of that report, analysts expect profit of $1.87 per share for the quarter, Barchart columnist Neha Panjwani wrote. 3

Investors are also heading into a leadership change: P&G has said chief operating officer Shailesh Jejurikar will succeed Jon Moeller as president and chief executive officer effective Jan. 1, 2026, with Moeller becoming executive chairman. 4

At its last quarterly report in October, P&G maintained its fiscal 2026 outlook, including all-in sales growth of 1% to 5% and core earnings per share of $6.83 to $7.09, and flagged tariff and commodity-cost headwinds for the year. 5

For traders, the January report is likely to hinge on whether P&G can keep pricing strong without losing volume to cheaper alternatives, and whether it reiterates that full-year outlook as input costs and consumer spending remain in focus.

P&G’s ability to hold its ground while the broader market wobbles will keep it on the radar for investors rotating toward steadier earners into year-end, with the next catalysts clustered in early January and the Jan. 22 earnings call.

Stock Market Today

Home Depot stock price: jobs, inflation and a Feb. 24 earnings test loom

Home Depot stock price: jobs, inflation and a Feb. 24 earnings test loom

7 February 2026
Home Depot shares rose 0.7% to $385.15 Friday, trading between $379.10 and $386.37. Investors await a delayed U.S. jobs report Wednesday and CPI data Friday, both postponed by a brief government shutdown. Home Depot reports fourth-quarter earnings Feb. 24. The Dow closed above 50,000 for the first time.
JPMorgan stock price jumps 4% into weekend as Wall Street braces for a busy data week

JPMorgan stock price jumps 4% into weekend as Wall Street braces for a busy data week

7 February 2026
JPMorgan shares rose 3.95% to $322.40 Friday, outpacing other major banks as U.S. stocks rallied and the Dow closed above 50,000 for the first time. The bank recently completed a $3 billion subordinated notes offering. Investors are watching for delayed U.S. jobs data and inflation figures next week, ahead of JPMorgan’s Feb. 23 company update.
AbbVie stock price: ABBV ends week near $223 after earnings swing — what to watch next

AbbVie stock price: ABBV ends week near $223 after earnings swing — what to watch next

7 February 2026
AbbVie shares rose 2% to $223.43 Friday, capping a volatile week marked by earnings and drug sales scrutiny. Moody’s upgraded AbbVie’s credit rating to A2, citing strong performance in immunology and neuroscience. Investors remain focused on Skyrizi and Rinvoq growth amid rising competition and recent regulatory filings. Trading volume stayed below average, with the stock still 9% off its 52-week high.
SK hynix stock price slips into Monday after S&P upgrade, tech selloff

SK hynix stock price slips into Monday after S&P upgrade, tech selloff

7 February 2026
SK hynix shares closed at 839,000 won, down 0.36% Friday and 8% for the week, as tech stocks retreated across Asia. S&P Global Ratings upgraded the chipmaker to “BBB+” with a positive outlook, citing strong HBM sales. The KOSPI fell 1.4% Friday, ending a six-week winning streak. Traders await Monday’s Seoul open for signs of further tech weakness.
Bitcoin steadies near $87,500 as Strategy discloses fresh buy; crypto-linked stocks mixed
Previous Story

Bitcoin steadies near $87,500 as Strategy discloses fresh buy; crypto-linked stocks mixed

Dow slides as tech gives back gains into year-end, Fed minutes ahead
Next Story

Dow slides as tech gives back gains into year-end, Fed minutes ahead

Go toTop